175 related articles for article (PubMed ID: 27349772)
1. A mechanistic study on the inhibition of α-chymotrypsin by a macrocyclic peptidomimetic aldehyde.
Zhang X; Bruning JB; George JH; Abell AD
Org Biomol Chem; 2016 Aug; 14(29):6970-8. PubMed ID: 27349772
[TBL] [Abstract][Full Text] [Related]
2. Structure-based design of high-affinity macrocyclic peptidomimetics to block the menin-mixed lineage leukemia 1 (MLL1) protein-protein interaction.
Zhou H; Liu L; Huang J; Bernard D; Karatas H; Navarro A; Lei M; Wang S
J Med Chem; 2013 Feb; 56(3):1113-23. PubMed ID: 23244744
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and extended activity of triazole-containing macrocyclic protease inhibitors.
Pehere AD; Pietsch M; Gütschow M; Neilsen PM; Pedersen DS; Nguyen S; Zvarec O; Sykes MJ; Callen DF; Abell AD
Chemistry; 2013 Jun; 19(24):7975-81. PubMed ID: 23606616
[TBL] [Abstract][Full Text] [Related]
4. Design of Triazolium-Grafted Peptidomimetic Macrocycles with Facial Amphipathicity to Target Pathogenic Bacteria.
Guerinot C; Malige M; Charbonnel N; Malosse K; Jouffret L; Taillefumier C; Roy O; Forestier C; Faure S
Org Lett; 2024 May; 26(19):4088-4092. PubMed ID: 38709636
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antimicrobial activity against Pseudomonas aeruginosa of macrocyclic β-hairpin peptidomimetic antibiotics containing N-methylated amino acids.
Vetterli SU; Moehle K; Robinson JA
Bioorg Med Chem; 2016 Dec; 24(24):6332-6339. PubMed ID: 27240465
[TBL] [Abstract][Full Text] [Related]
6. New tripeptide-based macrocyclic calpain inhibitors formed by N-alkylation of histidine.
Chen H; Jiao W; Jones MA; Coxon JM; Morton JD; Bickerstaffe R; Pehere AD; Zvarec O; Abell AD
Chem Biodivers; 2012 Nov; 9(11):2473-84. PubMed ID: 23161629
[TBL] [Abstract][Full Text] [Related]
7. Correlation of low-barrier hydrogen bonding and oxyanion binding in transition state analogue complexes of chymotrypsin.
Neidhart D; Wei Y; Cassidy C; Lin J; Cleland WW; Frey PA
Biochemistry; 2001 Feb; 40(8):2439-47. PubMed ID: 11327865
[TBL] [Abstract][Full Text] [Related]
8. The role of N-terminal heterocycles in hydrogen bonding to α-chymotrypsin.
Schumann NC; Bruning J; Marshall AC; Abell AD
Bioorg Med Chem Lett; 2019 Feb; 29(3):396-399. PubMed ID: 30579793
[TBL] [Abstract][Full Text] [Related]
9. Selective Peptidomimetic Inhibitors of NTMT1/2: Rational Design, Synthesis, Characterization, and Crystallographic Studies.
Mackie BD; Chen D; Dong G; Dong C; Parker H; Schaner Tooley CE; Noinaj N; Min J; Huang R
J Med Chem; 2020 Sep; 63(17):9512-9522. PubMed ID: 32689795
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of peptide aldehydes via enzymatic acylation of amino aldehyde derivatives.
Voyushina TL; Potetinova JV; Milgotina EI; Stepanov VM
Bioorg Med Chem; 1999 Dec; 7(12):2953-9. PubMed ID: 10658601
[TBL] [Abstract][Full Text] [Related]
11. Structure-based design, synthesis, and evaluation of peptide-mimetic SARS 3CL protease inhibitors.
Akaji K; Konno H; Mitsui H; Teruya K; Shimamoto Y; Hattori Y; Ozaki T; Kusunoki M; Sanjoh A
J Med Chem; 2011 Dec; 54(23):7962-73. PubMed ID: 22014094
[TBL] [Abstract][Full Text] [Related]
12. Atropisomer Control in Macrocyclic Factor VIIa Inhibitors.
Glunz PW; Mueller L; Cheney DL; Ladziata V; Zou Y; Wurtz NR; Wei A; Wong PC; Wexler RR; Priestley ES
J Med Chem; 2016 Apr; 59(8):4007-18. PubMed ID: 27015008
[TBL] [Abstract][Full Text] [Related]
13. A diversity-oriented synthesis strategy enabling the combinatorial-type variation of macrocyclic peptidomimetic scaffolds.
Isidro-Llobet A; Hadje Georgiou K; Galloway WR; Giacomini E; Hansen MR; Méndez-Abt G; Tan YS; Carro L; Sore HF; Spring DR
Org Biomol Chem; 2015 Apr; 13(15):4570-80. PubMed ID: 25778821
[TBL] [Abstract][Full Text] [Related]
14. Peptidomimetics as protein arginine deiminase 4 (PAD4) inhibitors.
Trabocchi A; Pala N; Krimmelbein I; Menchi G; Guarna A; Sechi M; Dreker T; Scozzafava A; Supuran CT; Carta F
J Enzyme Inhib Med Chem; 2015 Jun; 30(3):466-71. PubMed ID: 25198885
[TBL] [Abstract][Full Text] [Related]
15. Diversity-oriented synthesis of macrocyclic peptidomimetics.
Isidro-Llobet A; Murillo T; Bello P; Cilibrizzi A; Hodgkinson JT; Galloway WR; Bender A; Welch M; Spring DR
Proc Natl Acad Sci U S A; 2011 Apr; 108(17):6793-8. PubMed ID: 21383137
[TBL] [Abstract][Full Text] [Related]
16. Design of amino acid aldehydes as transition-state analogue inhibitors of arginase.
Shin H; Cama E; Christianson DW
J Am Chem Soc; 2004 Aug; 126(33):10278-84. PubMed ID: 15315440
[TBL] [Abstract][Full Text] [Related]
17. Macrocyclic analogues of the diuretic insect neuropeptide helicokinin I show strong receptor-binding.
Tran Van C; Nennstiel D; Scherkenbeck J
Bioorg Med Chem; 2015 Jul; 23(13):3278-86. PubMed ID: 25960326
[TBL] [Abstract][Full Text] [Related]
18. Discovery of a new isomannide-based peptidomimetic synthetized by Ugi multicomponent reaction as human tissue kallikrein 1 inhibitor.
Barros TG; Santos JAN; de Souza BEG; Sodero ACR; de Souza AMT; da Silva DP; Rodrigues CR; Pinheiro S; Dias LRS; Abrahim-Vieira B; Puzer L; Muri EMF
Bioorg Med Chem Lett; 2017 Jan; 27(2):314-318. PubMed ID: 27914800
[TBL] [Abstract][Full Text] [Related]
19. Optimization of the potency and pharmacokinetic properties of a macrocyclic ghrelin receptor agonist (Part I): Development of ulimorelin (TZP-101) from hit to clinic.
Hoveyda HR; Marsault E; Gagnon R; Mathieu AP; Vézina M; Landry A; Wang Z; Benakli K; Beaubien S; Saint-Louis C; Brassard M; Pinault JF; Ouellet L; Bhat S; Ramaseshan M; Peng X; Foucher L; Beauchemin S; Bhérer P; Veber DF; Peterson ML; Fraser GL
J Med Chem; 2011 Dec; 54(24):8305-20. PubMed ID: 22106937
[TBL] [Abstract][Full Text] [Related]
20. Structural Studies Provide New Insights into the Role of Lysine Acetylation on Substrate Recognition by CARM1 and Inform the Design of Potent Peptidomimetic Inhibitors.
Zhang Y; Marechal N; van Haren MJ; Troffer-Charlier N; Cura V; Cavarelli J; Martin NI
Chembiochem; 2021 Dec; 22(24):3469-3476. PubMed ID: 34569136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
